Skip to content
The Policy VaultThe Policy Vault

EticovoMedical Mutual

Pyoderma Gangrenosum

Initial criteria

  • Patient age > 18 years
  • Patient has tried one systemic corticosteroid OR tried one immunosuppressant ≥ 2 months or was intolerant
  • Prescription by or in consultation with dermatologist

Reauthorization criteria

  • Patient established on therapy ≥ 4 months
  • Beneficial clinical response (improvement in lesion size, depth, number)
  • Symptom improvement (pain, tenderness of lesions)

Approval duration

initial 4 months, reauth 1 year